Abstract
Recent progress in mammalian genomics raises enormous expectations for rapid advances in global understanding of the genetic program. The Human Genome Sequencing Project and parallel sequencing efforts addressing other genomes are in their final stages and will bring to the public domain an influx of tens of thousands of previously unknown genes whose cellular function will remain to be evaluated. Although DNA sequence information may assist and facilitate functional and comparative analyses of model organisms, a combination of systematic genotype- and phenotype-driven functional approaches will play a critical role in the upcoming research defining the gene function. For its physiological similarity to humans and for its genetic manipulability, the mouse emerges as a key model mammalian organism in these efforts. One powerful strategy for phenotype-driven mutagenesis studies in mice combines chromosome engineering techniques with mutagenesis. There are three key elements of this strategy. First, using the LoxP / Cre recombination system in embryonic stem (ES) cells, coat color-tagged segmental deletion s and inversions are generated on selected chromosomes, and mouse strains are derived from these cells using conventional ES cell technology. These mice can serve as very potent and extremely convenient genetic tools that narrow the search area for gene(s) of interest to a limited chromosomal segment. Second, N-ethyl-N-nitrosourea, ENU, is used to mutagenize male mice in order to generate a source of genome-wide germ-line transmissible mutations. Third, mutagenized animals are crossed with inversion or deletion carriers to produce pedigrees uncovering ENU-induced recessive phenotypes. The genomic position of induced mutations underlying recessive phenotypes is instantly mapped to the chromosomal inversion or deletion intervals. Several large-scale projects have been launched using ENU alone or in combination with engineered chromosomes. A rapidly growing set of new phenotypes has begun to emerge from these studies which will ultimately provide insights into gene function.
Current Genomics
Title: Chromosome Engineering and ENU Mutagenesis: Their Use for Defining Gene Function
Volume: 4 Issue: 1
Author(s): Jan Klysik, Monica J. Justice and Allan Bradley
Affiliation:
Abstract: Recent progress in mammalian genomics raises enormous expectations for rapid advances in global understanding of the genetic program. The Human Genome Sequencing Project and parallel sequencing efforts addressing other genomes are in their final stages and will bring to the public domain an influx of tens of thousands of previously unknown genes whose cellular function will remain to be evaluated. Although DNA sequence information may assist and facilitate functional and comparative analyses of model organisms, a combination of systematic genotype- and phenotype-driven functional approaches will play a critical role in the upcoming research defining the gene function. For its physiological similarity to humans and for its genetic manipulability, the mouse emerges as a key model mammalian organism in these efforts. One powerful strategy for phenotype-driven mutagenesis studies in mice combines chromosome engineering techniques with mutagenesis. There are three key elements of this strategy. First, using the LoxP / Cre recombination system in embryonic stem (ES) cells, coat color-tagged segmental deletion s and inversions are generated on selected chromosomes, and mouse strains are derived from these cells using conventional ES cell technology. These mice can serve as very potent and extremely convenient genetic tools that narrow the search area for gene(s) of interest to a limited chromosomal segment. Second, N-ethyl-N-nitrosourea, ENU, is used to mutagenize male mice in order to generate a source of genome-wide germ-line transmissible mutations. Third, mutagenized animals are crossed with inversion or deletion carriers to produce pedigrees uncovering ENU-induced recessive phenotypes. The genomic position of induced mutations underlying recessive phenotypes is instantly mapped to the chromosomal inversion or deletion intervals. Several large-scale projects have been launched using ENU alone or in combination with engineered chromosomes. A rapidly growing set of new phenotypes has begun to emerge from these studies which will ultimately provide insights into gene function.
Export Options
About this article
Cite this article as:
Klysik Jan, Justice J. Monica and Bradley Allan, Chromosome Engineering and ENU Mutagenesis: Their Use for Defining Gene Function, Current Genomics 2003; 4 (1) . https://dx.doi.org/10.2174/1389202033350155
DOI https://dx.doi.org/10.2174/1389202033350155 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced AI Techniques in Big Genomic Data Analysis
The thematic issue on "Advanced AI Techniques in Big Genomic Data Analysis" aims to explore the cutting-edge methodologies and applications of artificial intelligence (AI) in the realm of genomic research, where vast amounts of data pose both challenges and opportunities. This issue will cover a broad spectrum of AI-driven strategies, ...read more
Applications of Single-cell Sequencing Technology in Reproductive Medicine
Single cell sequencing (SCS) technology utilizes individual cells' genetic material to sequence their genome, transcriptome, and epigenetics at the molecular level. It offers insights into cell heterogeneity and enables the study of limited biological materials. Since its recognition as a valuable technique in 2011, single cell sequencing has yielded numerous ...read more
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Deep learning in Single Cell Analysis
The field of biology is undergoing a revolution in our ability to study individual cells at the molecular level, and to integrate data from multiple sources and modalities. This has been made possible by advances in technologies for single-cell sequencing, multi-omics profiling, spatial transcriptomics, and high-throughput imaging, as well as ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Radioimmunotherapy of Solid Tumors: Searching for the Right Target
Current Drug Delivery Inhibition of Renin-Angiotensin System and Advanced Glycation End Products Formation: A Promising Therapeutic Approach Targeting on Cardiovascular Diseases
Cardiovascular & Hematological Agents in Medicinal Chemistry Laser Modified Phenothiazines and Hydantoins: Photo-products Characterisation and Application on Animal Eyes Pseudo-tumours
Letters in Drug Design & Discovery Colchicine, Biologic Agents and More for the Treatment of Familial Mediterranean Fever. The Old, the New, and the Rare
Current Medicinal Chemistry Mechanisms of Cytotoxicity of Anticancer Titanocenes
Anti-Cancer Agents in Medicinal Chemistry Understanding Heterogeneity in Supplementation Effects of Selenium in Men: A Study of Stratification Variables and Human Genetics in a Prospective Sample from New Zealand
Current Pharmacogenomics and Personalized Medicine Lactoferrin Derived Peptides: Mechanisms of Action and their Perspectives as Antimicrobial and Antitumoral Agents
Mini-Reviews in Medicinal Chemistry Crystal Structure and Interaction of Phycocyanin with β-Secretase: A Putative Therapy for Alzheimer's Disease
CNS & Neurological Disorders - Drug Targets Free Radical Attack on Cholesterol: Oxysterols as Markers of Oxidative Stress and as Bioactive Molecules
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) ABC Transporters and Drug Resistance in Patients with Epilepsy
Current Pharmaceutical Design Challenges and Opportunities from Basic Cancer Biology for Nanomedicine for Targeted Drug Delivery
Current Cancer Drug Targets Poly (Lactic-co-Glycolic Acid) & Tocopheryl Polyethylene Glycol Succinate Nanoparticles for the Treatment of Different Brain Cancers
Anti-Cancer Agents in Medicinal Chemistry Endothelial Dysfunction Induced by Cadmium and Mercury and its Relationship to Hypertension
Current Hypertension Reviews Molecular Mechanisms of Thiamine Utilization.
Current Molecular Medicine Bile Acids and Derivatives, Their Nuclear Receptors FXR, PXR and Ligands: Role in Health and Disease and Their Therapeutic Potential
Anti-Cancer Agents in Medicinal Chemistry Mechanisms of Resistance to Photodynamic Therapy
Current Medicinal Chemistry Selectivity, Binding Affinity, and Ionization State of Matrix Metalloproteinase Inhibitors
Current Pharmaceutical Design Class II Phosphoinositide 3-Kinases as Potential Novel Drug Targets
Current Signal Transduction Therapy Signal Transducer and Activator of Transcription 3 Signaling Pathway: A Potential Target in Sarcoma Treatment
Current Enzyme Inhibition Identification of Novel 5,6-Dimethoxyindan-1-one Derivatives as Antiviral Agents
Medicinal Chemistry